Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 545

4 ASX small caps poised for a big year

Despite the often-cited narrative, large caps actually out-perform small caps in Australia over the long term. But at different stages of the equity cycle, small caps come into their own and out-perform the broader indexes. This normally occurs where:

  1. Large caps have appreciated to the point where valuations are stretched.
  2. The ‘animal spirits’ (aka market confidence) return such that investors are prepared to take on more risk.
  3. The economic cycle is constrained, and hence provides limited growth across the broader market (large caps).
  4. There has been a period of relative under-performance with small caps.


Above: Small Caps have underperformed the ASX200 by ~20% over the past 3 years (IRESS)

Some of these conditions are now in place, and whilst we haven’t seen any concrete ‘evidence’ that a re-rating is afoot, we are starting to see small caps increasingly mentioned in the media and by professional investors. This means that it's time to do the work and ready the list, in the event that this segment begins to move.

Portfolio approach

Small caps are where fortunes are made and lost. But it is the latter that is often overlooked. Investing in smaller companies has a higher risk for a host of reasons:

  • The companies often have a shorter operating history.
  • There is likely to be less diversification across clients, geographies and operations.
  • Research coverage is often sparse, if it exists at all.
  • Corporate governance can be on the skinny side.
  • Stocks can get lost in the market; for example, there is only one BHP, but there are nearly 2,300 ‘small caps’ all vying for attention.
  • And of course, liquidity can be dangerously light.

Accordingly, investors should take a ‘portfolio approach’ when investing in smaller companies. This means spreading the designated capital amongst a portfolio of stocks to spread the risk. Irrespective of an investor’s expertise or experience, losses are inevitable. The focus is to choose a mix of quality emerging companies so that the overall portfolio generates an appropriate return. Small cap investing requires a shotgun, not a rifle.

The Katana portfolios currently hold in excess of 55 stocks. Most of these companies are in the ASX100 or ASX200. However, where we see a particularly lucrative risk-return proposition, we are prepared to back our work and take on smaller companies.

Recently, we have been buying four companies in the smaller end of the market.

Praemium Limited (PPS)

There are just under a dozen platforms on the market of any size, and PPS’s SMA and Powerwrap are collectively the 8th largest. Importantly, PPS is one of the 3 challenger players along with Netwealth and Hub24. And despite its size, PPS regularly ranks 4th for net inflows (in absolute, not relative terms).

The platform industry is a scale game. There is considerable operating leverage and every incremental dollar of funds under administration (FUA) disproportionately impacts profitability. PPS has around 2.5% of the market, yet it has a market capitalisation of <$200 million (or an enterprise value of just ~$160 million if we include the $40 million cash on the balance sheet). Netwealth and Hub 24 have approximately 3x the funds under management,, yet they are trading on valuations that mean their market capitalisations are 25x and 20x that of PPS.

It has taken Netwealth and Hub 24 the better part of a decade to get to where they are. Acquiring PPS would grow FUA by more than a third in one relatively quick and easy transaction. It is not surprising therefore that in November 2021, Netwealth lobbed a $1.50 bid for PPS. For a variety of reasons, a deal was not consummated. However, at the current price of 38 cents, it would be hard to see that both Hub24 and Netwealth would not be running the ruler over PPS.

Pepper Money Limited (PPM)

PPM is one of the best risk-return opportunities across our entire stock universe.

Anecdotally, there are some factors that indicate strong management, culture and operational excellence. For example, PPM has won the award for Best Specialist Lender for the past 11 years consecutively. Out of a field of several hundred, they have also been awarded Best Non-Bank Lender in 2017, 2019 and again in 2021 and 2022. In 2023 alone, PPM won a total of 11 awards.

On the distribution side, the PPM brand is well known and respected by mortgage brokers who have more than 22 years of distributing their products. Channel checks confirm that PPM is known for fast turnaround times, consistency, and great customer service. This has led to more than 20,000 brokers distributing their product - and this figure is growing by the month. In addition, Pepper has close to 40 white label partnerships with third parties (also increasing). This captive market now accounts for 45% of originations.

Prior to the 13 rate rises, PPM averaged an AUM growth of 21.3% per annum for 8 years. And considerably more at the bottom line, due to the operating leverage in the business. As the banks continue to retreat from asset financing and impose ever tightening criteria on home loans, non-banks such as PPM are well positioned to continue to grow market share.

Companies with high calibre management, strong growth rates and a consistent, definable strategy, normally trade at high double-digit earnings multiples. But the hysteria around cyclical fluctuations in net interest margin and loan volumes, has seen the stock sold down from its IPO price of $2.89 to the $1.30 level. Consensus PER is now 5.5x, and the net tangible asset backing is approximately $1.50 per share.

West African Resources Limited (WAF)

We are not aware of any 200,000 ounce per annum low-cost gold producers trading on a market capitalisation of less than $1 billion. For the 2023 calendar year, WAF produced 226,000 ounces from its Sanbrado mine at an all-in sustaining cost (AISC) of US$1,126 per ounce. This generated not only a significant paper profit, but more importantly strong operating cashflow. This factor alone justifies a notably higher valuation.

But the real appeal for Katana is the rapidly developing Kiaka gold project south of Sanbrado. This is a mid-scale but world class, low strip, open pit development. Company releases confirm a 19-year mine life averaging 220kozpa. With first production slated for the 2nd half of 2025, this will elevate combined production to >400,000 ounces per annum. On the current market capitalisation, this seems an excellent risk-reward opportunity.

As with every company (and especially smaller ones) it is important to understand why we believe it is ‘mispriced’. In the case of WAF, the market would appear to be concerned with two issues: 1) funding and 2) country risk.

In the case of the first issue, WAF have repeatedly stated that they are fully funded to first production and do not need to raise capital. As a worst case, if they need/choose to raise, it is unlikely to be more than $100 million to $200 million; which is a modest 10-20% of the current market cap. So not material, even in the “worst case scenario”.

With respect to Burkina Faso (country risk), there are superficially some valid concerns around sovereignty. But what investors may not be aware of is that:

  • West Africa is now the largest gold producing region globally.
  • Burkina Faso is the 2nd largest producer in West Africa.
  • Burkina Faso is ranked #1 for gold discoveries over the past decade.
  • The country is also ranked #1 globally for permitting times and construction costs.

Integrated Research Limited (IRI)

At a $54 million market capitalisation, this is a micro-cap in every sense. And given its erratic liquidity (turnover), this stock is not for the novice investor, trader, or anyone with a short time horizon.

We have tracked IRI for more than a decade, and as this short extract below illustrates, the price has experienced wild gyrations. Post covid, the stock rallied as high as $4.80, before plunging in early 2022 to the 30 cent mark. But over the past 18 months, the stock price has mapped out a clear accumulation phase. We are now awaiting a break-out to confirm that it is time to meaningfully re-build our position.


IRESS

As with all stocks in the Katana portfolio, we look for the fundamentals and technicals to align. And there are signs that this is finally occurring, with IRI recently releasing a positive trading update for the 1st half of FY24. Statutory revenue, EBITDA and EPS were all up on the previous corresponding period. Importantly, net cash (there is nil debt) also grew to $21.5 million, which represents nearly 40% of their market capitalisation. Research coverage is almost non-existent, but one of Bell Potter’s most respected analysts covers the stock and the broker has historically had a good handle on their operations. Their most recent note places IRI on a PER of 5.3x and they have increased their price target to $0.66 per share.

 

Romano Sala Tenna is Portfolio Manager at Katana Asset Management. This article is general information and does not consider the circumstances of any individual. Any person considering acting on information in this article should take financial advice. 

Past performance is not a guarantee of future performance. Stock market returns are volatile, especially over the short term.

 

RELATED ARTICLES

Four all-time best charts for every adviser and investor

Three all-time best tables for every adviser and investor

The tortoise wins in investing

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Avoiding wealth transfer pitfalls

Australia is in the early throes of an intergenerational wealth transfer worth an estimated $3.5 trillion. Here's a case study highlighting some of the challenges with transferring wealth between generations.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.